Ashutosh Mahapatra, MD, discusses the evolving role of interventional neurology and its expanding impact on cerebrovascular and neurovascular care.
Alexandra Bonner, MD discusses the evolving care landscape for Duchenne Muscular Dystrophy.
Anna Shapiro-Krew, MD explores the complex relationship between epilepsy and mental health, highlighting how early screening, collaborative care, and emerging insights into neuroinflammation are transforming outcomes for patients with seizure disorders.
David Streem, MD, reflects on four decades of addiction care at Cleveland Clinic, highlighting how integrated clinical practice, education, and research have advanced treatment for alcohol and drug use disorders.
James Liao, MD, explores the diagnostic power of gait analysis in neurology, highlighting how advanced tools like augmented reality and wearable technology help clinicians more effectively identify and manage movement disorders.
Dr. Mark Bain and Dr. Francois Bethoux discuss the next frontier in stroke recovery, highlighting the promising role of vagus nerve stimulation in enhancing neurorehabilitation outcomes.
Megan Jack, MD, PhD and Dennis Kao, MD explore the causes, diagnosis, and treatment of brachial plexus injuries, from trauma to surgical repair. This episode offers expert insight into nerve reconstruction and the latest advancements in care.
Alexandra Bonner, MD, discusses spinal muscular atrophy, keys for diagnosis, and considerations for treatment.
Nina Moore, MD, discusses the evolving understanding of the mechanical properties of blood vessels and the potential impact on cerebrovascular surgical decision-making.
Odinachi Oguh, MD, sheds light on the nuances of ataxia, particularly the identification and multidisciplinary care needed for managing this challenging condition.
Robert Fox, MD, explains progressive multiple sclerosis and discusses how the understanding of this disease has evolved in recent years in light of new therapies and research.
Rachael Ferrari, MD, addresses the mental health challenges patients face with intellectual and developmental disabilities (IDDs) and shares tools for how to better serve and support these individuals.
Thomas Mroz, MD, explains the surgical landscape of cervical spondylotic myelopathy treatment and discusses advancements in the field, along with promising research developments.
Stephen Ferber, MD, discusses the selection, administration and effectiveness of interventions for treatment-resistant psychiatric disorders.
Dylan Wint, MD, details the neuropsychiatric symptoms of dementia and their management.
Rebecca Kuenzler, MD, provides the latest insights on the diagnosis and treatment of amyotrophic lateral sclerosis.
Edward Kilbane, MD, addresses diagnosis of bipolar disorders and details the current treatment landscape.
Charles Bernick, MD, MPH, discusses efficacy, patient selection and safety surveillance for anti-amyloid agents.
Demitre Serletis, MD, PhD, details the current and future use of SEEG in the localization of seizure foci and surgical planning as part of a team that has completed more than 1,000 SEEG cases.
The incidence of behavioral health conditions in individuals with multiple sclerosis is four times higher than those with other neurological conditions. In this episode, Grace Tworek, PsyD, discusses the management of behavioral health conditions in MS.